Highlights
NASDAQ: GNMX       Aevi Genomic Medicine
Last Price Today's Change   Day's Range   Trading Volume
0.20   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):3,576,427
4 Weeks Range:0.145 - 0.29
4 Weeks Price Volatility (%):
68.97%
52 Weeks Range:0.11 - 0.347
52 Weeks Price Volatility (%):
57.64%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Medgenics (known as Aevi Genomic Medicine since December 2016) is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine. The firm's portfolio includes TARGT, for treatment of end-stage renal disease; β-thalassemia intermedia (Thalassemia patients require blood transfusion); and other developments.

  Be the first to like this.
 


 

651  3587  160  4570 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 BBT 54.24+0.75 
 ACHN 7.00+0.87 
 STI 70.13+0.87 
 NIO 3.85-0.81 
 SEMG 15.02-0.04 
Partners & Brokers